What Is Aesthetic Flat Closure, and Why Are So Many Patients Still Having to Fight for It?
(Based on a recent interview with Lacy Marie, founder of Boobless Life, discussing breast implant illness, patient self-advocacy, and life after aesthetic flat closure)
---
Lacey Marie almost did not survive her breast implants.
She was not in a car accident. She did not have a known diagnosis. She was simply a woman with silicone implants whose health had been declining for years, moving through the medical system without a clear answer, until she reached a point where her organs were involved and the situation had become critical.
When she finally connected the dots between her implants and her symptoms, her path forward became clear. What happened next was not as simple as it should have been.
The conversation I had with Lacey on a recent episode of my podcast covered ground that I believe every woman with implants, and every surgeon who treats them, needs to hear. It touched on genetic markers beyond BRCA, on why dense breast tissue creates surveillance blind spots, on the access gap between patients in major cities and those in rural areas, and on what it actually means to advocate for your own body when the medical system is pushing back.
At the center of it all was a question that more patients are asking out loud: if I have decided I do not want reconstruction, why is that decision being overridden by my surgeon?
---
From Unexplained Symptoms to a Life That Almost Ended
Lacey's experience with breast implant illness did not begin with a dramatic event. It began the way it begins for many women: gradually, with symptoms that seemed unrelated, fatigue that felt explainable, and a collection of concerns that were addressed individually rather than as part of a larger picture.
Over time, her health worsened significantly. She experienced symptoms that involved multiple organ systems. By the time she was close to a crisis point, she had been through a number of medical visits without a clear explanation connecting her systemic symptoms to her implants.
Some patients with implants report a wide range of symptoms, including fatigue, cognitive difficulty, joint pain, skin changes, and immune irregularities. The mechanisms behind these reports are still being studied, and not every patient experiences the same pattern. You can learn more about how we evaluate and address these patterns on our breast implant illness resource page: https://drrobertwhitfield.com/breast-implant-illness
What Lacey's story illustrates is how long that process of recognition can take, and what the cost of delay can be.
When she did connect with providers who understood this area, including an informed explant surgeon, the path toward symptom resolution began. Her recovery was not instant. But it was real, and she now lives a life she describes as healthier, more aligned with who she is, and more fulfilling than anything she experienced with implants.
---
Genetic Markers Beyond BRCA: A Conversation Many Women Are Not Having
One of the most clinically significant parts of my conversation with Lacy involved her genetic profile.
Most people are familiar with BRCA1 and BRCA2, the genes most commonly associated with hereditary breast and ovarian cancer risk. What many patients do not know is that there are additional genetic markers, including CHEK2, ATM, PALB2, and others, that also carry elevated risk and may inform decisions about prophylactic surgery.
Lacey carried genetic markers that put her at elevated risk for breast cancer. When her oncologist framed the situation plainly, saying it was not a matter of whether she would develop cancer but when, that clarity changed how she thought about her options. She asked a direct question: did she have to have breasts? Could they simply remove everything?
That question, and the resistance she initially encountered in having it taken seriously, is part of a much larger conversation about patient autonomy in surgical decision-making. She knew what she wanted. She was not in crisis, not confused, not making an impulsive choice. She was making an informed, values-aligned decision about her own body. The friction she experienced before finding a surgeon who respected that decision is something many women describe.
Comprehensive genetic testing for breast cancer risk is still not a routine part of every patient's care, particularly in areas with limited access to genetic counselors or specialized oncologists. This is an area where earlier information could meaningfully change the trajectory of care for many women.
---
What Is Aesthetic Flat Closure, and Why Does It Require Explanation?
Understanding the Procedure
Aesthetic flat closure refers to mastectomy performed with the intention of creating a smooth, flat chest wall, without the placement of a tissue expander, implant, or flap reconstruction. The surgeon removes the breast tissue and then carefully closes the chest in a way that minimizes excess skin and creates a clean, flat aesthetic result.
For many women, this is the preferred outcome. For some, it reflects a personal decision to not reconstruct. For others who carry high genetic risk and choose prophylactic mastectomy, it may simply be the right fit for their body and their life.
Aesthetic flat closure is not the same as a standard mastectomy that happens to leave the chest flat. The technique, tissue handling, and skin excision are different. A patient who receives a mastectomy from a surgeon who has not explicitly planned for aesthetic flat closure may end up with excess skin, dog ears, or a result that does not reflect the intention. Revision surgery is sometimes required.
The Pushback Patients Encounter
Lacey encountered a question that patients across the country report hearing when they request aesthetic flat closure: what if you change your mind?
That question, while perhaps well-intentioned, reflects a pattern in which the surgeon's assumptions about what a patient will eventually want take precedence over what the patient is actively stating she wants now. It treats her stated preference as provisional, as a position she has not fully thought through, rather than as an informed choice that deserves to be respected.
This is not a minor inconvenience. For patients in areas where there are few surgeons who perform aesthetic flat closure competently, hearing that pushback can mean either accepting a result they did not want, traveling significant distances to find a provider who will listen, or delaying care.
Lacey's organization, Boobless Life, exists in part because she found community with other women navigating this same tension, and because she believes patients deserve information and options before they walk into a surgical consultation. The work she does is about expanding what women know is possible, before they are in a vulnerable position having to argue for it.
---
Dense Breast Tissue and Why Standard Imaging Misses More Than Patients Realize
Dense breast tissue is a common finding. When breast tissue is dense, the tissue appears white on a mammogram, and tumors, which also appear white, can be significantly harder to detect. For women who had implants layered over dense tissue, that challenge is compounded.
Standard mammography has known limitations with dense tissue. Ultrasound can be used as a supplement but has its own sensitivity constraints. MRI provides more detailed imaging but is not universally available and is not covered by all insurance plans in all circumstances.
Lacey's story highlighted how this plays out in practice. She was not someone who was skipping screenings. She was navigating a system in which the tools available did not always capture what was present. This is a systemic issue, not a failure of individual women to be vigilant.
Emerging AI-assisted imaging tools are showing promise in improving detection rates in dense tissue. These systems are not yet universally deployed, but early evidence suggests they may improve sensitivity in ways that current standard imaging does not. I expect this to be one of the more significant developments in breast imaging over the next decade, and it deserves to be part of the conversation patients are having with their radiologists and primary care providers today.
---
The Access Gap: Why Your Zip Code Still Determines Your Options
At one point in our conversation, I noted that Spain fits inside Texas. What I meant by that is a contrast in how specialized care is distributed.
In regions with concentrated medical centers and specialty practices, patients may have multiple providers to choose from, can seek second opinions, and have access to genetic counselors, breast surgeons who perform aesthetic flat closure, explant specialists, and integrative practitioners all within a reasonable distance.
In rural areas or smaller markets, that same patient may have access to one general surgeon at a regional hospital. That surgeon may have excellent general training, but may not have specific experience with aesthetic flat closure, with explant surgery, or with the nuances of caring for patients who have experienced systemic symptoms associated with their implants.
This is not a criticism of individual providers. It is a structural reality that affects patient outcomes. Women in rural areas may receive care that reflects what is locally available rather than what is most aligned with their expressed preferences and clinical situation.
What this means practically is that some patients need to travel. They need to plan for that travel. And they need the information to know that traveling for a procedure they cannot find locally is a legitimate and sometimes necessary option, not an overreaction.
Telehealth and coordinated care models are beginning to close parts of this gap. At our Austin practice, we work with patients who travel from across the country because they cannot find what they need locally. The initial consultation is increasingly possible to conduct remotely, which at minimum helps patients understand their options before committing to a trip.
---
How the SHARP Framework Applies to Lacy's Story and to Your Recovery
The SHARP program, which stands for Strategic Holistic Accelerated Recovery Program, was developed to support patients through explant surgery and the recovery period that follows. It reflects a view of surgical preparation and recovery that goes beyond the procedure itself.
For patients who have experienced systemic symptoms associated with their implants, the body has often been managing an inflammatory burden for an extended period. That context matters when planning surgery. Pre-operative nutritional optimization, immune support, and metabolic assessment can influence how a patient moves through surgery and how they recover from it.
SHARP also incorporates considerations that are relevant to patients like Lacey: genetics, gut health, hormonal patterns, and the relationship between tissue health and surgical outcomes. For patients undergoing mastectomy, particularly those with a history of implant-related inflammation or systemic symptoms, this kind of comprehensive preparation is not optional. It is part of what sets a recovery trajectory.
Our pre and post-surgery essentials collection was developed to support patients through each phase of the SHARP preparation and recovery process: https://drrobssolutions.com/collections/pre-post-surgery-essentials
The SHARP methodology is detailed in my book, available at: https://drrobssolutions.com/products/sharp-by-dr-robert-whitfield
---
What Lacy's Life Looks Like Now
One of the things I always appreciate about conversations like the one I had with Lacy is hearing what happens on the other side.
She is clear: she is healthier, more at peace, and more fully herself now than she ever felt with implants. She describes her body as her own in a way it did not feel before. She is running Boobless Life, building community, and helping other women find the information and the clinical support they need to make decisions that are right for them.
That is not a universal outcome. Not every patient who undergoes explant surgery reports complete symptom resolution, and the timeline for improvement varies. But it is a real outcome for many patients, and it is worth hearing.
---
Take the Next Step
If you are evaluating your options related to implant removal, aesthetic flat closure, or systemic symptoms you believe may be connected to your implants, the first step is getting a clear picture of where you are.
- Take the Health Assessment: https://drrobertwhitfield.com/health-assessment
- Download the Free Inflammation Guide: https://drrobertwhitfield.com/inflammation-guide
- Schedule a Discovery Call: https://discovery.drrobertwhitfield.com/form
- Shop Pre and Post-Surgery Essentials: https://drrobssolutions.com/collections/pre-post-surgery-essentials
- Buy Dr. Robert Whitfield's book about SHARP: https://drrobssolutions.com/products/sharp-by-dr-robert-whitfield
---
Medical Disclaimer: This content is for educational and informational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical evaluation, diagnosis, or treatment. Individual outcomes vary. Consult a qualified healthcare provider before making any decisions about your care.